Related Products of 1317-39-1, Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. Mentioned the application of 1317-39-1, Name is Copper(I) oxide.
The impact of surface treatment of the support on the oxidation of CO over carbon-supported Wacker-type catalyts was studied. This study focused on the effect of the chemical properties of activated carbon on CO oxidation over supported PdCl2-CuCl2 and PdCl2-CuCl2-Cu(NO)32 catalyts. The surface of active carbon used to prepare supported Wacker-type catalysts was enriched with carboxylic acid and carbonyl groups by pretreating with HNO3 or adding Cu(NO3)2 as a supplementary copper precursor. These surface groups improved the hydrophilicity and facilitated the formation of an active copper phase (Cu2Cl(OH)3). The effects were stronger, particularly on the formation of Cu2Cl(OH)3, when Cu(NO3)2 was combined with CuCl2 as catalyst precursors. The acceleration of CO oxidation can be attributed to the formation of the active copper phase and the improved hydrophilicity.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1317-39-1, and how the biochemistry of the body works.Related Products of 1317-39-1
Reference：
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”